Rose Bengal-decorated Silica Nanoparticles As Photosensitizers for Inactivation of Gram-positive Bacteria
Overview
Authors
Affiliations
A new type of photosensitizer, made from Rose Bengal (RB)-decorated silica (SiO(2)-NH(2)-RB) nanoparticles, was developed to inactivate gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), with high efficiency through photodynamic action. The nanoparticles were characterized microscopically and spectroscopically to confirm their structures. The characterization of singlet oxygen generated by RB, both free and immobilized on a nanoparticle surface, was performed in the presence of anthracene-9,10-dipropionic acid. The capability of SiO(2)-NH(2)-RB nanoparticles to inactivate bacteria was tested in vitro on both gram-positive and gram-negative bacteria. The results showed that RB-decorated silica nanoparticles can inactivate MRSA and Staphylococcus epidermidis (both gram-positive) very effectively (up to eight-orders-of-magnitude reduction). Photosensitizers of such design should have good potential as antibacterial agents through a photodynamic mechanism.
Comprehensive Approaches to Combatting Biofilms: From Biofilm Structure to Phage-Based Therapies.
Grygiel I, Bajrak O, Wojcicki M, Krusiec K, Jonczyk-Matysiak E, Gorski A Antibiotics (Basel). 2024; 13(11).
PMID: 39596757 PMC: 11591314. DOI: 10.3390/antibiotics13111064.
In Vitro Antimicrobial Photodynamic Therapy for () and (MRSA) Inhibition Using a Green Light Source.
Roa-Tort K, Saavedra Y, Villanueva-Martinez A, Ganem-Rondero A, Perez-Carranza L, de la Rosa-Vazquez J Pharmaceutics. 2024; 16(4).
PMID: 38675180 PMC: 11053950. DOI: 10.3390/pharmaceutics16040518.
Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells.
Uddin M, Bekmukhametova A, Antony A, Barman S, Houang J, Wu M Molecules. 2024; 29(2).
PMID: 38276623 PMC: 10820979. DOI: 10.3390/molecules29020546.
Metal nanoparticles as inhibitors of enzymes and toxins of multidrug-resistant .
Joshi A, Patil R Infect Med (Beijing). 2024; 2(4):294-307.
PMID: 38205183 PMC: 10774769. DOI: 10.1016/j.imj.2023.11.006.
Sato M, Oshiro-Junior J, Rodero C, Boni F, Araujo V, Bauab T Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631009 PMC: 10459110. DOI: 10.3390/ph16081094.